Parallel Advisors, LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 160 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,801
+7.2%
568
+68.0%
0.00%
Q2 2023$1,680
+14.1%
338
+13.4%
0.00%
Q1 2023$1,472
-21.5%
2980.0%0.00%
Q4 2022$1,874
+87.4%
298
+140.3%
0.00%
Q3 2022$1,000
-85.7%
124
-78.9%
0.00%
Q2 2022$7,000
-12.5%
588
-32.7%
0.00%
Q1 2022$8,000
-57.9%
874
-31.5%
0.00%
-100.0%
Q4 2021$19,000
-42.4%
1,2760.0%0.00%0.0%
Q3 2021$33,000
-23.3%
1,276
-23.4%
0.00%
-50.0%
Q2 2021$43,000
-4.4%
1,665
+31.6%
0.00%0.0%
Q1 2021$45,000
+40.6%
1,2650.0%0.00%0.0%
Q4 2020$32,000
-39.6%
1,265
-9.6%
0.00%
-33.3%
Q3 2020$53,000
+35.9%
1,399
+51.7%
0.00%0.0%
Q2 2020$39,000
+95.0%
922
-12.4%
0.00%
+50.0%
Q1 2020$20,000
+185.7%
1,052
+317.5%
0.00%
+100.0%
Q4 2019$7,0000.0%2520.0%0.00%0.0%
Q3 2019$7,0000.0%2520.0%0.00%0.0%
Q2 2019$7,0000.0%2520.0%0.00%0.0%
Q1 2019$7,0002520.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders